Ledger.Open graph →
SEC Form D · Amendment · filed November 16, 2017

Nohla Therapeutics Inc

Offering
$41.5M
Sold
$32.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Brian Daniels · Seattle, WADirectorMichael Sistenich · Seattle, WADirectorSteven Gillis · Seattle, WADirectorLawrence D. Gozlan · Seattle, WADirectorAndrew S. Wilder · Toronto, Ontario, CanadaDirectorRussell Holmes · San Diego, CADirectorRussell S. Fryer · Toronto, Ontario, CanadaDirectorRobert S. Klein · Toronto, Ontario, CanadaDirectorKathleen Fanning · Seattle, WAExec · DirectorGreg Vital · Georgetown, TNDirectorPaul E. Hodges, Iii · Bloomfield Township, MIDirectorRonald D. Poe · Riva, MDDirectorGeorge D. Doney · Riva, MDDirectorKathleen Fanning · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗